Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
MMWR Recomm Rep ; 72(1): 1-25, 2023 03 10.
Artículo en Inglés | MEDLINE | ID: mdl-36893044

RESUMEN

Chronic hepatitis B virus (HBV) infection can lead to substantial morbidity and mortality. Although treatment is not considered curative, antiviral treatment, monitoring, and liver cancer surveillance can reduce morbidity and mortality. Effective vaccines to prevent hepatitis B are available. This report updates and expands CDC's previously published Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection (MMWR Recomm Rep 2008;57[No. RR-8]) regarding screening for HBV infection in the United States. New recommendations include hepatitis B screening using three laboratory tests at least once during a lifetime for adults aged ≥18 years. The report also expands risk-based testing recommendations to include the following populations, activities, exposures, or conditions associated with increased risk for HBV infection: persons incarcerated or formerly incarcerated in a jail, prison, or other detention setting; persons with a history of sexually transmitted infections or multiple sex partners; and persons with a history of hepatitis C virus infection. In addition, to provide increased access to testing, anyone who requests HBV testing should receive it, regardless of disclosure of risk, because many persons might be reluctant to disclose stigmatizing risks.


Asunto(s)
Hepatitis B Crónica , Hepatitis B , Hepatitis C , Adulto , Humanos , Estados Unidos/epidemiología , Adolescente , Virus de la Hepatitis B , Hepatitis B Crónica/diagnóstico , Hepatitis B Crónica/epidemiología , Hepatitis B/diagnóstico , Hepatitis B/epidemiología , Hepatitis B/prevención & control , Centers for Disease Control and Prevention, U.S.
2.
Open Forum Infect Dis ; 9(1): ofab599, 2022 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-34988259

RESUMEN

BACKGROUND: Clinical severity of coronavirus disease 2019 (COVID-19) may vary over time; trends in clinical severity at admission during the pandemic among hospitalized patients in the United States have been incompletely described, so a historical record of severity over time is lacking. METHODS: We classified 466677 hospital admissions for COVID-19 from April 2020 to April 2021 into 4 mutually exclusive severity grades based on indicators present on admission (from most to least severe): Grade 4 included intensive care unit (ICU) admission and invasive mechanical ventilation (IMV); grade 3 included non-IMV ICU and/or noninvasive positive pressure ventilation; grade 2 included diagnosis of acute respiratory failure; and grade 1 included none of the above indicators. Trends were stratified by sex, age, race/ethnicity, and comorbid conditions. We also examined severity in states with high vs low Alpha (B.1.1.7) variant burden. RESULTS: Severity tended to be lower among women, younger adults, and those with fewer comorbidities compared to their counterparts. The proportion of admissions classified as grade 1 or 2 fluctuated over time, but these less-severe grades comprised a majority (75%-85%) of admissions every month. Grades 3 and 4 consistently made up a minority of admissions (15%-25%), and grade 4 showed consistent decreases in all subgroups, including states with high Alpha variant burden. CONCLUSIONS: Clinical severity among hospitalized patients with COVID-19 has varied over time but has not consistently or markedly worsened over time. The proportion of admissions classified as grade 4 decreased in all subgroups. There was no consistent evidence of worsening severity in states with higher vs lower Alpha prevalence.

3.
MMWR Morb Mortal Wkly Rep ; 70(36): 1235-1241, 2021 Sep 10.
Artículo en Inglés | MEDLINE | ID: mdl-34499626

RESUMEN

Long-term symptoms often associated with COVID-19 (post-COVID conditions or long COVID) are an emerging public health concern that is not well understood. Prevalence of post-COVID conditions has been reported among persons who have had COVID-19 (range = 5%-80%), with differences possibly related to different study populations, case definitions, and data sources (1). Few studies of post-COVID conditions have comparisons with the general population of adults with negative test results for SARS-CoV-2, the virus that causes COVID-19, limiting ability to assess background symptom prevalence (1). CDC used a nonprobability-based Internet panel established by Porter Novelli Public Services* to administer a survey to a nationwide sample of U.S. adults aged ≥18 years to compare the prevalence of long-term symptoms (those lasting >4 weeks since onset) among persons who self-reported ever receiving a positive SARS-CoV-2 test result with the prevalence of similar symptoms among persons who reported always receiving a negative test result. The weighted prevalence of ever testing positive for SARS-CoV-2 was 22.2% (95% confidence interval [CI] = 20.6%-23.8%). Approximately two thirds of respondents who had received a positive test result experienced long-term symptoms often associated with SARS-CoV-2 infection. Compared with respondents who received a negative test result, those who received a positive test result reported a significantly higher prevalence of any long-term symptom (65.9% versus 42.9%), fatigue (22.5% versus 12.0%), change in sense of smell or taste (17.3% versus 1.7%), shortness of breath (15.5% versus 5.2%), cough (14.5% versus 4.9%), headache (13.8% versus 9.9%), and persistence (>4 weeks) of at least one initially occurring symptom (76.2% versus 69.6%). Compared with respondents who received a negative test result, a larger proportion of those who received a positive test result reported believing that receiving a COVID-19 vaccine made their long-term symptoms better (28.7% versus 15.7%). Efforts to address post-COVID conditions should include helping health care professionals recognize the most common post-COVID conditions and optimize care for patients with persisting symptoms, including messaging on potential benefits of COVID-19 vaccination.


Asunto(s)
Prueba de COVID-19/estadística & datos numéricos , COVID-19/complicaciones , COVID-19/diagnóstico , SARS-CoV-2/aislamiento & purificación , Adolescente , Adulto , Anciano , COVID-19/epidemiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estados Unidos/epidemiología , Adulto Joven , Síndrome Post Agudo de COVID-19
4.
MMWR Morb Mortal Wkly Rep ; 70(27): 967-971, 2021 07 09.
Artículo en Inglés | MEDLINE | ID: mdl-34237048

RESUMEN

As of June 30, 2021, 33.5 million persons in the United States had received a diagnosis of COVID-19 (1). Although most patients infected with SARS-CoV-2, the virus that causes COVID-19, recover within a few weeks, some experience post-COVID-19 conditions. These range from new or returning to ongoing health problems that can continue beyond 4 weeks. Persons who were asymptomatic at the time of infection can also experience post-COVID-19 conditions. Data on post-COVID-19 conditions are emerging and information on rehabilitation needs among persons recovering from COVID-19 is limited. Using data acquired during January 2020-March 2021 from Select Medical* outpatient rehabilitation clinics, CDC compared patient-reported measures of health, physical endurance, and health care use between patients who had recovered from COVID-19 (post-COVID-19 patients) and patients needing rehabilitation because of a current or previous diagnosis of a neoplasm (cancer) who had not experienced COVID-19 (control patients). All patients had been referred to outpatient rehabilitation. Compared with control patients, post-COVID-19 patients had higher age- and sex-adjusted odds of reporting worse physical health (adjusted odds ratio [aOR] = 1.8), pain (aOR = 2.3), and difficulty with physical activities (aOR = 1.6). Post-COVID-19 patients also had worse physical endurance, measured by the 6-minute walk test† (6MWT) (p<0.001) compared with control patients. Among patients referred to outpatient rehabilitation, those recovering from COVID-19 had poorer physical health and functional status than those who had cancer, or were recovering from cancer but not COVID-19. Patients recovering from COVID-19 might need additional clinical support, including tailored physical and mental health rehabilitation services.


Asunto(s)
Instituciones de Atención Ambulatoria , COVID-19/rehabilitación , Derivación y Consulta , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , COVID-19/diagnóstico , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento , Estados Unidos , Adulto Joven
5.
Interv. psicosoc. (Internet) ; 24(2): 89-95, ago. 2015. tab
Artículo en Inglés | IBECS | ID: ibc-140884

RESUMEN

Little is known about how the knowledge, attitudes, and behaviors of the public child welfare workforce influence implementation of evidence-based practice (EBP) as most research has focused on the private workforce. This paper reports on public child welfare staff knowledge, attitudes, and practices in a state implementing the EBP, SafeCare. A survey of public child welfare staff (N = 222) was conducted to assess knowledge, familiarity, and referral barriers and practices. Knowledge of and familiarity with SafeCare were low, especially among front line staff (case managers). Attitudes toward SafeCare were fairly positive, but somewhat less so than attitudes toward a standard, non-evidenced based parenting program. Case managers were significantly less likely to have made a referral (15%) than other staff (46%). Job tenure had few effects on familiarity, knowledge, attitudes, or referrals. The strongest predictors of having made referrals were familiarity with SafeCare and job position


Se sabe poco sobre cómo influyen el conocimiento, las actitudes y las conductas de los profesionales del sistema público de protección infantil en la implantación de programas basados en la evidencia (PBE), ya que gran parte de la investigación sobre este tema se ha centrado en el ámbito privado. Este artículo informa acerca de los conocimientos, las actitudes y las prácticas de un equipo público de protección infantil que lleva la implantación en un Estado de EE.UU. de un PBE (SafeCare). Se aplicó una encuesta a 222 profesionales que trabajaban en protección infantil para evaluar el conocimiento, la familiaridad y las dificulta- des y prácticas de derivación de casos. El conocimiento y la familiaridad con SafeCare® era bajo, especialmente entre profesionales de primera línea (responsables de casos). Las actitudes hacia SafeCare eran bastante positivas, pero un poco menos que las actitudes hacia un programa utilizado habitualmente y no basado en la evidencia. Los responsables de casos tenían significativamente menos posibilidades de derivar (15%) que otros profesionales (46%). La antigüedad en el trabajo influye poco en el conocimiento, las actitudes o las derivaciones al programa. Los predictores que más influyeron en el número de derivaciones a SafeCare fueron la familiaridad con el programa y el tipo de contrato laboral


Asunto(s)
Niño , Femenino , Humanos , Masculino , Terapéutica/métodos , Terapéutica/psicología , Conocimientos, Actitudes y Práctica en Salud , Práctica Clínica Basada en la Evidencia/métodos , Práctica Clínica Basada en la Evidencia/estadística & datos numéricos , Práctica Clínica Basada en la Evidencia/tendencias , Responsabilidad Parental/psicología , Protección a la Infancia/psicología , Protección a la Infancia/tendencias , Responsabilidad Parental/tendencias , Salud Infantil/estadística & datos numéricos , Cuidado del Niño/métodos , Cuidado del Niño/psicología , Autocuidado/métodos , Autocuidado/psicología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...